LY3537031 for Liver Function Study
We are investigating how LY3537031 affects people with normal liver function and those with mild to severe liver impairment. This study aims to learn more about its safety and effectiveness in different liver health conditions.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
CRU Hungary Kft.
Kistarcsa, Hungary
Summit Clinical Research s.r.o.
Department of Internal Medicine and Clinical Pharmacology
Bratislava, Slovakia
Sponsor: Eli Lilly & Co.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.